{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:37:11Z","timestamp":1786628231354,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Orthop Relat Res"],"DOI":"10.1097\/corr.0000000000004100","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:01:41Z","timestamp":1786626101000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["CORR Insights\u00ae: Is Dose Reduction After Initial Treatment With Denosumab Associated With Subsequent Skeletal-related Events, Osteonecrosis of the Jaw, or Osteoporotic Fractures in Patients With Metastatic Carcinoma? A Nationwide Retrospective Comparative Study"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0450-7821","authenticated-orcid":false,"given":"Adam S.","family":"Levin","sequence":"first","affiliation":[{"name":"Assistant Professor, Orthopaedic Surgery Department, Johns Hopkins University, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"R1-20260813","doi-asserted-by":"crossref","first-page":"100507","DOI":"10.1016\/j.jbo.2023.100507","article-title":"The low and disproportionate utilization of antiresorptive therapy in patients with osseous metastasis","volume":"43","author":"Agarwal","year":"2023","journal-title":"J Bone Oncol"},{"key":"R2-20260813","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.3390\/jcm14186469","article-title":"Comparative efficacy and cost-effectiveness of denosumab versus zoledronic acid in cancer patients with bone metastases","volume":"14","author":"Aliyev","year":"2025","journal-title":"J Clin Med"},{"key":"R3-20260813","doi-asserted-by":"crossref","first-page":"e2611885","DOI":"10.1001\/jamanetworkopen.2026.11885","article-title":"Medical record abstraction for quality improvement in sepsis care using artificial intelligence: a cluster randomized trial","volume":"9","author":"Boussina","year":"2026","journal-title":"JAMA Netw Open"},{"key":"R4-20260813","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.bone.2012.05.010","article-title":"Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy","volume":"51","author":"Chang","year":"2012","journal-title":"Bone"},{"key":"R5-20260813","article-title":"Is dose reduction after initial treatment with denosumab associated with subsequent skeletal-related events, osteonecrosis of the jaw, or osteoporotic fractures in patients with metastatic carcinoma? A nationwide retrospective comparative study","volume":"7","author":"Heng","year":"2026","journal-title":"Clin Orthop Relat Res"},{"key":"R6-20260813","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/jamaoncol.2016.6316","article-title":"Continued treatment effect of zoledronic acid dosing every 12 vs 4 weeks in women with breast cancer metastatic to bone: the OPTIMIZE-2 randomized clinical trial","volume":"3","author":"Hortobagyi","year":"2017","journal-title":"JAMA Oncol"},{"key":"R7-20260813","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/cncr.11571","article-title":"Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma","volume":"98","author":"Lipton","year":"2003","journal-title":"Cancer"},{"key":"R8-20260813","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.5435\/JAAOS-D-23-00332","article-title":"Life expectancy after treatment of metastatic bone disease: an international trend analysis","volume":"32","author":"Rogers","year":"2024","journal-title":"J Am Acad Orthop Surg"},{"key":"R9-20260813","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann Oncol"},{"key":"R10-20260813","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/jnci\/djh141","article-title":"Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer","volume":"96","author":"Saad","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R11-20260813","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1200\/JCO.2017.73.7437","article-title":"Cost-effectiveness analysis of monthly zoledronic acid, zoledronic acid every 3 months, and monthly denosumab in women with breast cancer and skeletal metastases: CALGB 70604 (Alliance)","volume":"35","author":"Shapiro","year":"2017","journal-title":"J Clin Oncol"},{"key":"R12-20260813","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"28","author":"Stopeck","year":"2010","journal-title":"J Clin Oncol"},{"key":"R13-20260813","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/j.jfas.2019.02.008","article-title":"The epidemiology of metatarsal fractures among older females with bisphosphonate exposure","volume":"59","author":"West","year":"2020","journal-title":"J Foot Ankle Surg"}],"container-title":["Clinical Orthopaedics & Related Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CORR.0000000000004100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:01:43Z","timestamp":1786626103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CORR.0000000000004100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":13,"URL":"https:\/\/doi.org\/10.1097\/corr.0000000000004100","relation":{},"ISSN":["0009-921X","1528-1132"],"issn-type":[{"value":"0009-921X","type":"print"},{"value":"1528-1132","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"2026-07-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}